Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P53 mutation does not affect prognosis in ovarian epithelial malignancies.

The Journal of pathology - 1 May 2001

Fallows S, Price J, Atkinson R J, Johnston P G, Hickey I, Russell S E

Abstract excerpt

Mutations of the p53 tumour suppressor gene have been found in most human cancers, including ovarian epithelial malignancies. This study investigated whether the presence or absence of p53 mutation was associated with outcome following platinum-based chemotherapy in patients with ovarian cancer. DNA samples from tumour tissue and blood were obtained from 73 patients with primary tumours, 50 of whom received...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to Chemotherapy, Adjuvant
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Multivariate Analysis

Share to Ovarian Neoplasms

Share to Polymorphism, Single-Stranded Conformational

Share to Survival Rate

Source

Identifiers

PMID: 11329143
DOI: 10.1002/path.857

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P53 mutation does not affect prognosis in ovarian epithelial malignancies.PMID 11329143Read ↗

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.Semantic proximity Read ↗

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.Semantic proximity Read ↗

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.Semantic proximity Read ↗

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.Semantic proximity Read ↗

P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance.Semantic proximity Read ↗

TP53 and ovarian cancer.Semantic proximity Read ↗

TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma.Semantic proximity Read ↗

Critical evaluation of p53 as a prognostic marker in ovarian cancerSemantic proximity Read ↗

Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.Semantic proximity Read ↗

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.Semantic proximity Read ↗

p53 mutation is a common genetic event in ovarian carcinoma.Semantic proximity Read ↗

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.